Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

5.6%

2 terminated out of 36 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

14%

5 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed with results

Key Signals

1 with results86% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (10)
P 1 (1)
P 4 (5)

Trial Status

Completed12
Not Yet Recruiting8
Recruiting7
Unknown5
Terminated2
Active Not Recruiting1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (36)

Showing 20 of 20 trials
NCT07486791Not ApplicableRecruitingPrimary

A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin

NCT07422688Not ApplicableEnrolling By Invitation

Optical Coherence Tomography in Acute Vessel Evaluation

NCT07474441Completed

Early Coronary Angiography in Advanced Chronic Kidney Disease With Acute Coronary Syndrome

NCT06899776Active Not RecruitingPrimary

Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department

NCT07351643Phase 4Not Yet RecruitingPrimary

CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes in Non-diabetic ACS Patients Without HF

NCT07283809RecruitingPrimary

European Unified Registries for Heart Care Evaluation and Randomised Trials Italy

NCT07264881Not Yet Recruiting

For Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed Treatment in One Procedure, Avoiding a Return Hospital Visit for a Second Operation.

NCT07231835Recruiting

Registry of Coronary Disease Outcomes Revascularizing With Drug-Coated Balloons

NCT06095557Not ApplicableCompletedPrimary

MCG Discovery Study in Emergency Departments

NCT07203846Phase 4Not Yet RecruitingPrimary

Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor

NCT07026708RecruitingPrimary

TIRANA-ACS: A Prospective Registry Study for the Targeted Investigation of Residual Inflammation After Non-ST/ ST Elevation Acute Coronary Syndrome

NCT07190274Not Yet Recruiting

Prospective Observational Cohort Study on Impact of Frailty on Risk Prediction, Treatment Strategies, and Short-Term Outcomes in Patients With Acute Coronary Syndrome

NCT07096973Recruiting

Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery

NCT07064109Not ApplicableRecruitingPrimary

Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients

NCT07157670Not Yet Recruiting

Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

NCT07128667Not Yet RecruitingPrimary

Clinical Features and Long-Term Prognosis in Young Patients With Acute Myocardial Infarction

NCT05378321Not ApplicableCompleted

Prevalence of NAFLD in ACS Patients

NCT06620744Not ApplicableCompletedPrimary

Magnetocardiography (MCG) Device Use in Patients With Elevated Troponin

NCT06757777Not Yet Recruiting

Evaluation of Remnant Cholesterol Levels and Monocyte-to-HDL-cholesterol Ratio As Predictors of Coronary Artery Disease Severity in Patients with Acute Coronary Syndrome

NCT06759272Phase 4Not Yet Recruiting

Impact of CYP2C19 Genotype-guided Approach in Antiplatelet Therapy on Platelet Reactivity Index Among Coronary Artery Disease (CAD) Patients

Scroll to load more

Research Network

Activity Timeline